Vertex Pharmaceuticals Inc. officer Stuart A. Arbuckle is set to sell 4,804 shares of common stock on 02/20/2024, with an aggregate market value of approximately $2,021,475. The shares to be sold were recently acquired on 02/17/2024, through restricted stock vesting and performance shares, both as part of compensation from the issuer. This transaction follows a recent history of sales by Arbuckle over the past three months, totaling 12,898 shares for gross proceeds of $5,237,527.8.
Vertex Pharmaceuticals Inc. officer Stuart A. Arbuckle is set to sell 4,804 shares of common stock on 02/20/2024, with an aggregate market value of approximately $2,021,475. The shares to be sold were recently acquired on 02/17/2024, through restricted stock vesting and performance shares, both as part of compensation from the issuer. This transaction follows a recent history of sales by Arbuckle over the past three months, totaling 12,898 shares for gross proceeds of $5,237,527.8.